Athena Gold Q1 2026 operating loss narrows to CAD 206,434

Athira Pharma, Inc.

Athira Pharma, Inc.

ATHA

0.00

  • Athena Gold posted a net loss of CAD 2.04 million in the three months ended March 31, 2026, swinging from net income of CAD 147,652 a year earlier.
  • Operating loss narrowed to CAD 206,434 from CAD 378,602, as exploration and evaluation costs shifted to a CAD 104,601 recovery from a CAD 76,623 expense.
  • Unrealized investment losses drove results, with a CAD 1.84 million loss on investments versus a CAD 105,100 gain a year earlier.
  • Cash totaled CAD 2.86 million at March 31, 2026, with working capital of CAD 5.69 million; unspent flow-through commitments were about CAD 2.1 million.
  • Started a fully funded ~5,000-meter, ~10-hole maiden drill program at Laird Lake; Ontario awarded a non-repayable CAD 200,000 OJEP grant.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Athena Gold Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-004368), on May 29, 2026, and is solely responsible for the information contained therein.